Melissa Rhodes MD in Calhoun, Georgia

Home Georgia Calhoun

Melissa Rhodes MD has Pulmonary Disease as her primary medical specialty. Their primary office is: 100 Hospital Ct in Calhoun, Georgia.

They're a part of the: Respiratory Consultants Of Georgia Llc medical group which has around 5 members. You can call their office at 678-721-0705 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Indiana University School Of Medicine and graduated in 1993 (around 31 years of experience). They are listed as doing telehealth appointments.

Melissa B Rhodes MD Office Phone and Directions

Melissa Rhodes MD
Respiratory Consultants Of Georgia Llc
100 Hospital Ct
Calhoun, Georgia 30701
678-721-0705

Patient Ratings
Please rate your experience with Melissa Rhodes MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 678-721-0705

Enter a starting address:

Healthcare Info for Melissa Rhodes MD

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS)

Medical School: Indiana University School Of Medicine
Graduation Year: 1993
The Primary Medical Specialty for Melissa Rhodes MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 31
PAC (PECOS ID)#: 8628092764
NPI #: 1396743308
NPI Created On: 07/13/2005
NPI Last Updated Listed as: 06/09/2021
Primary Taxonomy Code: 207RC0200X
License Number:
47060
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Alliant Health Plans
Medicare

They are listed as accepting new patients.

Services and Procedures include:

X-ray of chest, 2 views
Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage
Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
Measurement and graphic recording of total and timed exhaled air capacity
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Test for exercise-induced lung stress
Determination of lung volumes using plethysmography
Measurement of lung diffusing capacity
Overnight measurement of oxygen saturation in blood using ear or finger device
Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Critical care delivery critically ill or injured patient, first 30-74 minutes
Critical care delivery critically ill or injured patient

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788192611

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: UPTRAVI

Open Associated Drug #1: 66215-602-14

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788192613

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: UPTRAVI

Open Associated Drug #1: 66215-602-14

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: OPSUMIT

Associated Drug #2: 66215-501-30

Payments Total: $141

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792919807

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: FACIAL AESTHETICS

Name of Drug #1: BOTOX

Open Associated Drug #1: 0023-1145-01

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795822279

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795822283

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795822287

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10

Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801682867

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801683391

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801683433

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801684931

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Pulmonary Disease Professionals in Calhoun

1.
Timothy Lin

100 Hospital Ct
Calhoun, GA
Respiratory Consultants Of Georgia Llc

2.
Suzette Chin MD

100 Hospital Ct
Calhoun, GA
Respiratory Consultants Of Georgia Llc

Providers in Respiratory Consultants Of Georgia Llc

1.Suzette Chin Md

100 Hospital Ct
Calhoun Ga 30701-2077
Respiratory Consultants Of Georgia Llc
Pulmonary Disease

2.Timothy Lin

21 Pointe N Dr
Cartersville Ga 30120
Respiratory Consultants Of Georgia Llc
Pulmonary Disease

3.Timothy Lin

100 Hospital Ct
Calhoun Ga 30701-2077
Respiratory Consultants Of Georgia Llc
Pulmonary Disease

4.Jacqueline Reid

21 Pointe N Dr
Cartersville Ga 30120
Respiratory Consultants Of Georgia Llc
Nurse Practitioner

5.Melissa Rhodes Md

100 Hospital Ct
Calhoun Ga 30701-2077
Respiratory Consultants Of Georgia Llc
Pulmonary Disease

6.Rebekah Smithey

21 Pointe N Dr
Cartersville Ga 30120
Respiratory Consultants Of Georgia Llc
Nurse Practitioner

View all 5 members of Respiratory Consultants Of Georgia Llc medical group